Feline injection site sarcomas

Veterinary Clinics of North America - Small Animal Practice

Volumn 32, Issue 4, 2002, Pages 983-995

  Séguin, Bernard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEMANNAN; ADJUVANT; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FELINE LEUKEMIA VIRUS VACCINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IMMUNOSTIMULATING AGENT; INACTIVATED VACCINE; INACTIVATED VIRUS VACCINE; INTERLEUKIN 12; INTERLEUKIN 2; IRIDIUM 192; MITOXANTRONE; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN C JUN; PROTEIN P53; RABIES VACCINE; VINCRISTINE; VIRUS VACCINE;

ALLERGIC VASCULITIS; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CAT DISEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CARCINOGENICITY; DRUG INDUCED CANCER; INCIDENCE; INJECTION SITE; LUNG METASTASIS; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; RISK ASSESSMENT; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; VETERINARY MEDICINE; VIRUS CARCINOGENESIS;

ANIMALIA; FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS;

EID: 0036630728     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(02)00022-0     Document Type: Review

References (52)

1. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine-associated sarcomas in cats: 78 cases (1996-2000)
2. Drug injection-associated fibrosarcoma in a cat
3. Soft tissue sarcomas
4. Comparison of fibrosarcomas that developed at vaccination sites and at nonvaccination sites in cats: 239 cases (1991-1992)
5. Vaccine-associated feline sarcomas
6. The potential role of inflammation in the development of postvaccinal sarcomas in cats
7. Focal cutaneous vasculitis and alopecia at sites of rabies vaccination in dogs
8. Focal necrotizing granulomatous panniculitis associated with subcutaneous injection of rabies vaccine in cats and dogs: 10 cases (1988-1989)
9. Do injection site reactions induce fibrosarcomas in cats?
10. Estimated prevalence of injection-site sarcomas in cats during 1992
11. Postvaccinal sarcomas in the cat: Epidemiology and electron probe microanalytical identification of aluminum
12. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma, tumorigenesis in cats
13. Do postvaccinal sarcomas occur in Australian cats?
14. Vaccine site-associated sarcomas in cats: Clinical experience and laboratory review (1982-1993)
15. Feline vaccine-associated sarcomas
16. Postvaccinal sarcomas in the cat: Histology and immunohistochemistry
17. Feline vaccine-associated sarcomas: Current studies on pathogenesis
18. Feline vaccine-associated sarcomas
19. Clinical and morphologic features of post-traumatic ocular sarcomas in cats
20. Intraocular spindle cell sarcoma following ocular trauma in a cat: Case report and literature review
21. Primary ocular sarcomas in the cat
22. Postvaccinal sarcomas in cats
23. The application of adjuvants to veterinary medicine
24. Characterization of chromosomal aberrations in feline vaccine-associated sarcoma using comparative genomic hybridization
25. P53 expression in feline vaccinal sarcomas
26. P53 tumor suppressor gene alterations in vaccine-associated feline sarcoma
27. Presence of p53 mutations in feline neoplasms
28. Novel p53 tumor suppressor mutations in cases of spindle cell sarcoma, pleomorphic sarcoma and fibrosarcoma in cats
29. Immunohistochemical detection of tumor suppressor gene p53 protein in feline injection site-associated sarcomas
30. Use of immunohistochemistry and polymerase chain reaction for detection of oncornaviruses in formalin-fixed, paraffin-embedded fibrosarcomas from cats
31. Evaluation of formalin-fixed paraffin-embedded tissues from vaccine site-sarcomas of cats for polyornavirus DNA and antigen
32. Diagnosis and treatment of suspected sarcomas
33. Radiation therapy and surgery for fibrosarcoma in 33 cats
34. Prognosis for presumed feline vaccine-associated sarcoma after excision: 61 cases (1986-1996)
35. Widespread metastasis of a fibrosarcoma associated with vaccination site in a cat
36. Metastasizing liposarcoma associated with a vaccination site in a cat
37. Pulmonary metastasis of a feline vaccine-site fibrosarcoma
38. The utility of contrast enhanced computed tomography in feline vaccine-associated sarcomas: 35 cases
39. Surgical excision of soft tissue sarcomas in cats
40. Evaluation of marking materials for cutaneous surgical margins
41. Recent advances in the treatment of vaccine-associated sarcomas
42. Modified wide local excision for vaccine associated soft tissue sarcomas in cats
43. The combination of surgery and radiation in the treatment of cancer. A review
44. Preliminary results of post-surgical iridium-192 brachytherapy for vaccine-associated sarcomas in 18 cats
45. Combined doxorubicin and cyclo-phosphamide chemotherapy for nonresectable feline fibrosarcoma
46. Treatment with combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine-associated sarcomas: 25 cases (1995-2000)
47. Prolonged remission and survival time in cats with injection-site associated sarcomas using preoperative radiation and doxorubicin protocol: 61 cases (1998-2000)
48. Hyperthermia effect on uptake of technetium-99M labeled liposomes in feline sarcomas
49. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2
50. Use of an immunostimulant as an aid in treatment and management of fibrosarcoma in three cats
51. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas
52. Feline vaccination guidelines